Metsera backers establish new biotech armed with China-licensed immunology asset - Pharmaceutical Technology

PHP and ARCH have established Sentivera, a biotech that now has an immunology licensing deal with China-based Haisco. PHP and ARCH have founded Sentivera, a biotech that now has an immunology licensing deal with China-based Haisco. Population Health Partners and ARCH Venture Partners have teamed up to found Sentivera, a US biotech about which little information is currently available. Credit: eamesBot/Shutterstock.com. Fresh off a blockbuster sale to Pfizer, the investors behind Metsera are putting their expertise and business strategy to work again. Population Health Partners and ARCH Venture Partners have teamed up to found Sentivera, a US biotech shrouded in…

Source: Pharmaceutical Technology